Skip to content

Clinical trials

Psychotic Disorders trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Country / region: Greece Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Oxford3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Aristotle University Of Thessaloniki1
Janssen-Cilag International NV1
KAVADIA ELENI1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Rakitzi, Stavroula1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders10
Schizophrenia5
Anxiety Disorders2
Adjustment Disorders1
Affective Disorders, Psychotic1
Alzheimer Disease1
Autism Spectrum Disorder1
Bipolar Disorder1
Cognitive Dysfunction1
Mood Disorders1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.